Victory Capital Management
HUMA icon

Victory Capital Management’s Humacyte HUMA Stock Holding History

Victory Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Buy
23,262
+4,504
+24% +$4.17K ﹤0.01% 2447
2026
Q1 		$11.4K Buy
18,758
+544
+3% +$566 ﹤0.01% 2393
2025
Q4 		$17.5K Buy
18,214
+3,117
+21% +$4.41K ﹤0.01% 2393
2025
Q3 		$26.3K Buy
15,097
+103
+0.7% +$202 ﹤0.01% 2384
2025
Q2 		$31.3K Buy
14,994
+2,405
+19% +$4.62K ﹤0.01% 2414
2025
Q1 		$21.5K Sell
12,589
-322
-2% -$1.21K ﹤0.01% 2424
2024
Q4 		$65.2K Sell
12,911
-63,985
-83% -$317K ﹤0.01% 2366
2024
Q3 		$418K Buy
76,896
+65,095
+552% +$429K ﹤0.01% 2056
2024
Q2 		$56.6K Buy
11,801
+667
+6% +$3.47K ﹤0.01% 2354
2024
Q1 		$34.6K Buy
11,134
+1,035
+10% +$3.48K ﹤0.01% 2406
2023
Q4 		$28.7K Buy
+10,099
New +$25.9K ﹤0.01% 2483

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Victory Capital Management's HUMA Position: Q2 2026 in Review

Victory Capital Management increased its Humacyte (HUMA) stake by 24% in Q2 2026, buying an estimated $4.17K and bringing the position to 23,262 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Victory Capital Management first reported a position in HUMA in Q4 2023 and has held it in 11 quarters since. The position peaked at $418K in Q3 2024. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Victory Capital Management held 23,262 shares of Humacyte worth $18.2K as of Q2 2026.
  • Victory Capital Management bought 4,504 Humacyte shares in Q2 2026, an estimated $4.17K.
  • Humacyte made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2447 holding.
  • Victory Capital Management first reported a position in Humacyte in Q4 2023 and has held it in 11 quarters since.
  • Victory Capital Management's Humacyte position peaked at $418K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.